![Elena Feinstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elena Feinstein is currently the Chief Scientific Officer at Quark Pharmaceuticals, Inc. She holds a doctorate degree from Weizmann Institute of Science and Moscow University.
| Unternehmen | Position | Ende |
|---|---|---|
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Health Technology |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moscow University
 Moscow University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
